Clinical Trials Browser

sintilimab × Thoracic × 30 days × Clear all

NCT05549037 2026-06-03

LungTIME-C01

Phase 3 Completed

Carcinoma, Non-Small-Cell Lung

NCT07603661 2026-05-22

Sintilimab Plus Chemotherapy as Induction Therapy for Unresectable Stage IIIC NSCLC

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung